Production of an engineering batch, cgmp batch, delivery, and shelf-life study of ammonium tetrathiomolibdate (attm) capsules for use in clinical trial for possible cancer treatment.
Ended Awarded Last action
- Contract number
- 75N91022F00002
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $321,255
Award facts
- Contract value 59% obligated
-
- $321,255.00 Current, with exercised options
- $546,667.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Terminate for Convenience | -$56,875 | |
| Supplemental Agreement for work within scope | -$35,000 | |
| Original award | $413,130 |
About this award
This firm-fixed-price delivery order was awarded to Societal CDMO San Diego, LLC (a division of Recro Pharma, Inc.) by the National Cancer Institute, part of the National Institutes of Health at the Department of Health and Human Services. The $546,667.00 contract is for the production of an engineering batch, current Good Manufacturing Practice (cGMP) batch, delivery, and shelf-life study of ammonium tetrathiomolybdate (ATTM) capsules to support a clinical trial for a potential cancer treatment. The contract is not set aside for any specific business type. It is an order under the Drug Formulation and Manufacturing Contracts 2019 indefinite delivery vehicle held by Societal CDMO San Diego, which provides pharmaceutical development, manufacturing, and testing services to federal agencies like the VA and HHS to support their translational science and clinical research initiatives.
Quick answers
Who was awarded contract 75N91022F00002?
75N91022F00002 was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on March 8, 2022.
How much is contract 75N91022F00002 worth?
The government has obligated $321,255 on 75N91022F00002. Its potential value, with all options, is $546,667.
Is contract 75N91022F00002 an order under another contract?
Yes. 75N91022F00002 is a delivery order under 75N98019D00058, an indefinite delivery contract, on Drug Formulation and Manufacturing Contracts 2019.
Was contract 75N91022F00002 competed?
The extent of competition for 75N91022F00002 was full and open competition after exclusion of sources. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award